CCIRC Starts Preparing For Clinical Research Review; To Include Group Achievements, Problems
In Brief: NCI Authorization Should be $1.3 Billion, Humphrey Tells Kennedy; GOG Gets New Life
Groups’ Growth, Impact Shown by Five-Year Data
CCIRC Members Now Feel At Home In DCT
Book Related History Of Cancer Act
GAO Eppley Report Offers Lessons for Grantees, Contractors
Trending Stories
- As his Senate testimony alleged danger from mRNA COVID vaccine, El-Deiry had an offer to run NCI Frederick lab
The job offer to run the lab—home to virus research, RAS Initiative, and data science—was quickly rescinded - Peter F. Garrett to people with cancer: Your story has power
- OMB proposed rule could end 50% of currently active clinical trials, Stand up for Science analysis finds
- Proposed OMB rule aims at the heart of the U.S. research enterprise—and scientists are fighting back
“The question isn’t whether politics will influence research. Under this proposal, that’s the point. That’s their goal.” - What NHS-Galleri taught us—and what it didn’t
- The NHS-Galleri trial has and will continue to provide critical insights to refine future MCED studies









